Literature DB >> 13016903

A preliminary study of apparent biological flase positive reactions in four serological tests for syphilis, and the treponemal immobilization test.

S OLANSKY, A HARRIS, J H HILL.   

Abstract

Keywords:  MALARIA/diagnosis; SYPHILIS/diagnosis

Mesh:

Year:  1953        PMID: 13016903

Source DB:  PubMed          Journal:  Am J Syph Gonorrhea Vener Dis        ISSN: 0096-6738


× No keyword cloud information.
  17 in total

1.  [ON THE HUMORALOGY OF NEUROSYPHILIS].

Authors:  H MATIAR-VAHAR
Journal:  Dtsch Z Nervenheilkd       Date:  1963-11-07

2.  [Contribution to lues serology. III. The technical difficulties of the Nelson test and the defective reproducibility of its findings].

Authors:  G FROMM; J MEYER-ROHN
Journal:  Arch Klin Exp Dermatol       Date:  1959

3.  Incidence of Treponema pallidum immobilizing antibody in rabbit immune sera against various types of micro-organisms and viruses.

Authors:  H A NIELSEN; M METZGER
Journal:  Br J Vener Dis       Date:  1959-12

4.  Evaluation of diagnostic tests in infection.

Authors:  C HOWE
Journal:  Bull N Y Acad Med       Date:  1955-10

5.  Studies on the reproducibility and specificity of the treponemal immobilization test.

Authors:  P J SEQUEIRA; A E WILKINSON
Journal:  Br J Vener Dis       Date:  1955-09

6.  The Treponema pallidum immobilization test.

Authors:  H A NIELSEN; A REYN
Journal:  Bull World Health Organ       Date:  1956       Impact factor: 9.408

7.  TPI test as a daily routine laboratory procedure.

Authors:  A HARRIS
Journal:  Am J Public Health Nations Health       Date:  1956-06

8.  Present status of serological tests for syphilis.

Authors:  A HARRIS; S OLANSKY
Journal:  Bull World Health Organ       Date:  1956       Impact factor: 9.408

9.  Biologically false positive reactions to serological tests for syphilis.

Authors:  G H KOSTANT
Journal:  Bull World Health Organ       Date:  1956       Impact factor: 9.408

10.  SELECT bibliography.

Authors: 
Journal:  Bull World Health Organ       Date:  1956       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.